IL1B and type 2 diabetes mellitus: It must be pointed out that the insulitis in T1DM is mainly driven by an autoimmune-mediated process rather than an autoinflammatory process as observed in T2DM, and this different mechanism suggests that IL-1 blockade may not be considered a good strategy to inhibit the pathogenesis of T1DM [5,15].